U.S. Markets closed

Salix Pharmaceuticals (SLXP) Soars: Stock Adds 11.4% in Session

Zacks Equity Research

Salix Pharmaceuticals Ltd. (SLXP) was a big mover last session, as its shares rose over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent trend for the company, as the stock is now up nearly 23% in the past one-month timeframe.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Salix Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the med-drugs industry include Aerie Pharmaceuticals, Inc. (AERI), Ariad Pharmaceuticals Inc. (ARIA) and Aeolus Pharmaceuticals Inc. (AOLS). All three carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




AEOLUS PHARMACEUTICL (AOLS): Free Stock Analysis Report

AERIE PHARMACEUTICALS INC (AERI): Free Stock Analysis Report

ARIAD PHARMACEUTICALS INC (ARIA): Free Stock Analysis Report

SALIX PHARMACEUTICALS LTD (SLXP): Free Stock Analysis Report


Zacks Investment Research